中文名称:磺咪达唑
  • Satranidazole
  • Satranidazole [INN]; Go 10213; 1-(1-Methyl-5-nitro-1H-imidazol-2-yl)-3-(methylsulfonyl)-2-imidazolidinone; 1-Methylsulfonyl-3-(1-methyl-5-nitro-2-imidazolyl)-2-imidazolidinone; 5-25-09-00447 (Beilstein Handbook Reference); BRN 0848345; C 10213 Go; Satranidazol; Satranidazol [Spanish]; Satranidazolum; Satranidazolum [Latin]; UNII-4N7G8A6439; 1-(1-Methyl-5-nitroimidazol-2-yl)-3-(methylsulfonyl)-2-imidazolidinone; 2-Imidazolidinone, 1-(1-methyl-5-nitro-1H-imidazol-2-yl)-3-(methylsulfonyl)-; 1-(1-methyl-5-nitro-1H-imidazol-2-yl)-3-(methylsulfonyl)imidazolidin-2-one
  • 56302-13-7
  • C8H11N5O5S
  • 289.2684
  • InChI=1/C8H11N5O5S/c1-10-6(13(15)16)5-9-7(10)11-3-4-12(8(11)14)19(2,17)18/h5H,3-4H2,1-2H3
  • 磺咪达唑 56302-13-7
  • 1.77g/cm3
  • 505.2°C at 760 mmHg
  • 259.3°C
  • 2.48E-10mmHg at 25°C